Roche Holding AG (OTCMKTS:RHHVF – Get Free Report)’s share price dropped 3.3% on Thursday . The stock traded as low as $433.37 and last traded at $449.03. Approximately 87,761 shares changed hands during trading, an increase of 185% from the average daily volume of 30,797 shares. The stock had previously closed at $464.19.
Roche Stock Down 3.3%
The firm has a 50 day moving average price of $447.53 and a 200 day moving average price of $387.65.
Roche Company Profile
Roche Holding AG, traded on the OTCMKTS under the symbol RHHVF, is a leading global healthcare company with two core business divisions: Pharmaceuticals and Diagnostics. The company focuses on developing innovative medicines and diagnostic tests that address serious diseases, driving advances in personalized healthcare and precision medicine.
In its Pharmaceuticals division, Roche pioneers targeted therapies across oncology, immunology, ophthalmology and neuroscience. Flagship products include monoclonal antibodies and small-molecule treatments such as Herceptin, Avastin and Actemra, which have become standards of care for cancer and autoimmune conditions.
Read More
- Five stocks we like better than Roche
- Silver Is the New Oil—And the World’s Running Dry
- BNZI stands out as a Zacks Buy. Earnings momentum and analyst upgrades align
- What happened in Cyprus could be coming here
- Elon Musk’s $1 Quadrillion AI IPO
- Buffett, Gates and Bezos Quietly Dumping Stocks—Here’s Why
Receive News & Ratings for Roche Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Roche and related companies with MarketBeat.com's FREE daily email newsletter.
